| Popis: |
1. Furth PA, Kazakis AM. Nail pigmentation changes associated with azidothymidine (zidovudine) [Abstract]. Ann Intern Med 1987;107:350. 2. Pannwalker AP. Nail pigmentation in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1987; 107:943-4. 3. Gonzalcz-Lahoz JM, Garcia Aguado C, MartinezFernandez R, et al. Pigmentation azulada en las unas de los pacientes con SIDA: efecto colateral de la zidovudina? [Letter] Rev Clin Espan 1988;183:278-9. 4. Azon-Masoliver A, Mallolas J, Gatell J, et al. Zidovudineinduced nail pigmentation. Arch Dermatol 1988;124: 1570-1. 5. Riechman DD, Fieschl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind controlled trial. N Engl J Med 1987;317:192-7. 6. McEvoy GK, ed. American Hospital Formulary Service: drug information. Bethesda, Md.: American Society of Hospital Pharmacists, 1988:392-7. 7. Daniel CR, Scher RK. Nail changes secondary to systemic drugs or ingestants.J AMACAD DERMATOL 1984;10:250-8. |
